Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan Saloner

Showing results (61-70 of 196) with videos related to

Pageof 20
Sort By:
Health Affairs (Project Hope)|October 6, 2025
Medicaid Expansion Boosted Specialty Treatment Episodes For Substance Use Disorder In Expansion States, 2010-22Johanna Catherine Maclean, Skyler Hulser, Bradley D Stein, et al.
American Journal of Preventive Medicine|March 22, 2021
COVID-19 Cases Among Employees of U.S. Federal and State PrisonsJulie A Ward, Kalind Parish, Grace DiLaura, et al.
Substance Abuse|April 2, 2021
It will end in tiers: A strategy to include "dabblers" in the buprenorphine workforce after the X-waiverBrendan Saloner, Barbara Andraka Christou, Adam J Gordon, et al.
JAMA Network Open|July 9, 2026
Xylazine-Fentanyl Positivity and Concentration in Urine Drug TestsOlivia K Sugarman, Charles Marks, Penn Whitley, et al.
Medical Care|January 11, 2023
Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel FrameworkBrendan Saloner, Hsien-Yen Chang, G Caleb Alexander, et al.
Journal of Addiction Medicine|August 16, 2024
Medications for Opioid Use Disorder After Entering Residential Treatment: Evidence From Louisiana MedicaidWenshu Li, Matthew Eisenberg, Minna Song, et al.
Medical Care|November 15, 2017
Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty TreatmentMarcus A Bachhuber, Pooja K Mehta, Laura J Faherty, et al.
JAMA Internal Medicine|August 27, 2014
Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010Marcus A Bachhuber, Brendan Saloner, Chinazo O Cunningham, et al.
JAMA Health Forum|August 17, 2022
Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 PandemicAlyssa Shell Tilhou, Laura Dague, Brendan Saloner, et al.
Substance Abuse|September 7, 2023
Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations ActBrendan Saloner, Barbara Andraka-Christou, Bradley D Stein, et al.
Pageof 20

Showing results (61-70 of 196) with videos related to

Sort By:
Pageof 20
Health Affairs (Project Hope)|October 6, 2025
Medicaid Expansion Boosted Specialty Treatment Episodes For Substance Use Disorder In Expansion States, 2010-22Johanna Catherine Maclean, Skyler Hulser, Bradley D Stein, et al.
American Journal of Preventive Medicine|March 22, 2021
COVID-19 Cases Among Employees of U.S. Federal and State PrisonsJulie A Ward, Kalind Parish, Grace DiLaura, et al.
Substance Abuse|April 2, 2021
It will end in tiers: A strategy to include "dabblers" in the buprenorphine workforce after the X-waiverBrendan Saloner, Barbara Andraka Christou, Adam J Gordon, et al.
JAMA Network Open|July 9, 2026
Xylazine-Fentanyl Positivity and Concentration in Urine Drug TestsOlivia K Sugarman, Charles Marks, Penn Whitley, et al.
Medical Care|January 11, 2023
Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel FrameworkBrendan Saloner, Hsien-Yen Chang, G Caleb Alexander, et al.
Journal of Addiction Medicine|August 16, 2024
Medications for Opioid Use Disorder After Entering Residential Treatment: Evidence From Louisiana MedicaidWenshu Li, Matthew Eisenberg, Minna Song, et al.
Medical Care|November 15, 2017
Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty TreatmentMarcus A Bachhuber, Pooja K Mehta, Laura J Faherty, et al.
JAMA Internal Medicine|August 27, 2014
Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010Marcus A Bachhuber, Brendan Saloner, Chinazo O Cunningham, et al.
JAMA Health Forum|August 17, 2022
Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 PandemicAlyssa Shell Tilhou, Laura Dague, Brendan Saloner, et al.
Substance Abuse|September 7, 2023
Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations ActBrendan Saloner, Barbara Andraka-Christou, Bradley D Stein, et al.
Pageof 20